Response to Srivatsa et al, “The role of upadacitinib in refractory dermatomyositis: A systematic review”

Journal of the American Academy of Dermatology 2026

View at publisher

Authors: Hanlin Zhang, Keyun Tang, Jindi Feng, Hongzhong Jin

DOI: 10.1016/j.jaad.2025.12.096

Cited by: 0

References: 2

Fields of Study & Subjects

Inflammatory Myopathies and Dermatomyositis Systemic Sclerosis and Related Diseases Myasthenia Gravis and Thymoma

References 2